David A. Sallman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

David A. Sallman

Mar 2, 2025, 08:51 | Blog

Joshua Zeidner: Magrolimab plus Azacitidine vs Physician Choice in Newly Diagnosed TP53-mut AML

Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about recent paper he and…

Sep 2, 2024, 09:01 | Insight

Mrinal Patnaik: ARNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis

Mrinal Patnaik, Physician Scientist with the Division of Hematology, Department of Internal Medicine at Mayo…

Jul 9, 2024, 00:57 | Insight

Talha Badar: Outcome after stopping venetoclax and azacitidine

Talha Badar shared on X: “American Journal of Hematology, Blood Research Journal, Wiley Online Library.…

All: 3 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023